Departments of 1Pain Clinic and 2Anesthesiology, Shaoxing Traditional Chinese Medical Hospital, Shaoxing, China.
Am J Ther. 2017 Nov/Dec;24(6):e693-e700. doi: 10.1097/MJT.0000000000000393.
To investigate the efficacy of radiofrequency thermocoagulation (RFTC) in relieving refractory pain of knee osteoarthritis (OA), we selected 54 patients with chronic knee OA pain, 27 treated with RFTC (case group) and 27 receiving regular treatments (control group). Response evaluations were conducted before treatment, and at the termination of treatment, and 3-month follow-up, applying the visual analog scale, the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and American Knee Society Score (AKSS). Data analyses were performed with SPSS 21.0. At the termination of treatments and 3-month follow-ups, cases gained significantly increased scores in vitality, bodily pain, general health perceptions, physical functioning, and social role functioning by SF-36 scaling and in pain, range of motion, stability, walking, and stair climbing by AKSS (all P < 0.05). Controls received higher scores by AKSS in pain at the termination of treatments and in pain, range of motion, and walking at the termination of 3-month follow-ups (all P < 0.05). Both cases and controls presented significant difference between visual analog scale scores before treatments and those at the termination of 3-month follow-ups (both P < 0.05). All patients felt less pain after treatments, cases presenting better improvement (P < 0.05). Pain was stronger in females compared with males and in a positive correlation with age while had no obvious relation to disease course. In conclusion, RFTC may have better efficacy in relieving refractory pain and promoting function recovery in patients with knee OA than regular treatment.
为了探究射频热凝术(RFTC)缓解膝骨关节炎(OA)难治性疼痛的疗效,我们选择了 54 例慢性膝关节 OA 疼痛患者,其中 27 例接受 RFTC 治疗(病例组),27 例接受常规治疗(对照组)。采用视觉模拟评分法、健康调查简表 36 项(SF-36)和美国膝关节协会评分(AKSS)对治疗前、治疗结束时和 3 个月随访时进行疗效评价。数据分析采用 SPSS 21.0 统计软件。治疗结束时和 3 个月随访时,病例组 SF-36 量表的活力、躯体疼痛、总体健康感觉、身体功能和社会角色功能评分以及 AKSS 的疼痛、活动范围、稳定性、行走和上下楼梯评分均显著升高(均 P < 0.05);对照组治疗结束时 AKSS 评分的疼痛和 3 个月随访时疼痛、活动范围和行走评分均显著升高(均 P < 0.05)。两组治疗前与 3 个月随访时的视觉模拟评分均有显著差异(均 P < 0.05)。所有患者治疗后疼痛均减轻,病例组改善更明显(P < 0.05)。女性疼痛较男性强烈,与年龄呈正相关,与病程无明显关系。总之,RFTC 缓解膝 OA 患者难治性疼痛、促进功能恢复的疗效优于常规治疗。